drugset / Trial / NCT00819403
Simvastatin With or Without Ezetimibe and Atherothrombotic Biomarker Assessment
RandomizedCrossoverTriple-blindTreatment
Summary
To determine whether the combination of ezetimibe and simvastatin improves biomarkers of atherothrombosis compared to simvastatin alone in patients with the metabolic syndrome.
Timeline
- Start
- 2009-01
- Primary completion
- 2011-11
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ezetimibe | Unknown | 10 mg | — |
| Comparator | Simvastatin | Small molecule | 40 mg | — |